Biochemist Daniel Gallie of UC Riverside. (Photo credit: Steve Walag.)
Biochemist Daniel R. Gallie at the University of California, Riverside and his research team of Zhong Chen, Todd Young, Jun Ling, and Su-Chih Chang report in the March 18, 2003, issue of the Proceedings of the National Academy of Sciences (PNAS) that they have developed technology that increases the amount of vitamin C in plants, including grains, by increasing the amount of the enzyme that is responsible for recycling vitamin C. "The ability to increase the level of vitamin C in plant food will enhance their nutritive value," said Gallie, who is professor of biochemistry. The research was funded by the U.S. Department of Agriculture and the University of California Agricultural Experiment Station over the last 5 years.
Vitamin C, or ascorbic acid, is essential to prevent diseases, such as scurvy, that affect the connective tissue. It also improves cardiovascular and immune cell function and is used to regenerate vitamin E. In contrast to most animals, humans cannot make vitamin C and it must, therefore, be obtained regularly from dietary sources. Vitamin C is present at high levels in some fruits such as citrus and some green leafy vegetables, but present in low levels in those crops most important to humans such as grains.
"Once used, vitamin C can be regenerated by the enzyme dehydroascorbate reductase or DHAR," explained Gallie. "Through this means, plants recycle the vitamin so that it can be used repeatedly. If vitamin C is not salvaged by DHAR, it is quickly lost."
Iqbal Pittalwala | UC Riverside
Selectively Reactivating Nerve Cells to Retrieve a Memory
01.06.2020 | Universität Heidelberg
CeMM study reveals how a master regulator of gene transcription operates
01.06.2020 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering